IN 2007, with the passage of the Food and Drug Administration (FDA) Amendments Act, the FDA was granted new authority to require a Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits of a drug outweigh its risks. An REMS, which can be required at the time a drug is approved and/or once it has gone to [...]
AS WE GO TO PRESS with the fall 2010 edition of InterSections, nearly 100 ASHP members have just finished an intensive day lobbying congressional representatives and their staff members on issues critical to our profession. It has been a busy, but important, time for ASHP members and the patients they serve. With the passage of the Patient Protection and Affordable Care Act, [...]
ASHP Connect is the Society's new online community where members connect with each other and share ideas through our discussion board, blogs, social networking tools, RSS feeds, and more. Get started now and get connected!
